Reference Group Choice and Antibiotic Resistance Outcomes

Two types of cohort studies examining patients infected with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) were contrasted, using different reference groups. Cases were compared to uninfected patients and patients infected with the corresponding, susce...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaye, Keith S., Engemann, John J., Mozaffari, Essy, Carmeli, Yehuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2004
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323179/
https://www.ncbi.nlm.nih.gov/pubmed/15207068
http://dx.doi.org/10.3201/eid1006.020665
_version_ 1782229148408741888
author Kaye, Keith S.
Engemann, John J.
Mozaffari, Essy
Carmeli, Yehuda
author_facet Kaye, Keith S.
Engemann, John J.
Mozaffari, Essy
Carmeli, Yehuda
author_sort Kaye, Keith S.
collection PubMed
description Two types of cohort studies examining patients infected with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) were contrasted, using different reference groups. Cases were compared to uninfected patients and patients infected with the corresponding, susceptible organism. VRE and MRSA were associated with adverse outcomes. The effect was greater when uninfected control patients were used.
format Online
Article
Text
id pubmed-3323179
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-33231792012-04-17 Reference Group Choice and Antibiotic Resistance Outcomes Kaye, Keith S. Engemann, John J. Mozaffari, Essy Carmeli, Yehuda Emerg Infect Dis Dispatch Two types of cohort studies examining patients infected with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) were contrasted, using different reference groups. Cases were compared to uninfected patients and patients infected with the corresponding, susceptible organism. VRE and MRSA were associated with adverse outcomes. The effect was greater when uninfected control patients were used. Centers for Disease Control and Prevention 2004-06 /pmc/articles/PMC3323179/ /pubmed/15207068 http://dx.doi.org/10.3201/eid1006.020665 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Kaye, Keith S.
Engemann, John J.
Mozaffari, Essy
Carmeli, Yehuda
Reference Group Choice and Antibiotic Resistance Outcomes
title Reference Group Choice and Antibiotic Resistance Outcomes
title_full Reference Group Choice and Antibiotic Resistance Outcomes
title_fullStr Reference Group Choice and Antibiotic Resistance Outcomes
title_full_unstemmed Reference Group Choice and Antibiotic Resistance Outcomes
title_short Reference Group Choice and Antibiotic Resistance Outcomes
title_sort reference group choice and antibiotic resistance outcomes
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323179/
https://www.ncbi.nlm.nih.gov/pubmed/15207068
http://dx.doi.org/10.3201/eid1006.020665
work_keys_str_mv AT kayekeiths referencegroupchoiceandantibioticresistanceoutcomes
AT engemannjohnj referencegroupchoiceandantibioticresistanceoutcomes
AT mozaffariessy referencegroupchoiceandantibioticresistanceoutcomes
AT carmeliyehuda referencegroupchoiceandantibioticresistanceoutcomes

Ejemplares similares